News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|July 24, 2013

Where to Meet the Next Generation of Pharma Leaders

Publisher Russ Pratt on the Pharmaceutical Executive value proposition

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement

Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

ByMichael Christel,Michael Grosberg
April 17th 2026
Stock.adobe.com

Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market

ByMike Hollan
April 17th 2026
President Trump

President Trump Nominates Dr. Erica Schwarts for CDC Leadership Role

ByMike Hollan
April 17th 2026
Morten Graugaard Orbis Medicines

The Turning Point for Oral Biologics: Q&A With Morten Graugaard

ByNicholas Jacobus,Morten Graugaard
April 17th 2026
Richard Lowenthal

Bringing New Delivery Methods to Treatments: Q&A with Richard Lowenthal

ByMike Hollan,Richard Lowenthal
April 17th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market

2

The Turning Point for Oral Biologics: Q&A With Morten Graugaard

3

Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request

4

FDA’s Shift Signals a New Era for Data-Driven Drug Development

5

Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us